Missing/wrong data?
Log in to edit
Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).
scientific article published on 9 February 2017
Author/s
author: Salvatore Siena, Stephen V Liu, Andrea Sartore-Bianchi, Angelo Vanzulli, Silvia Damian, Filippo de Braud
Work details
Publication date
February 9, 2017
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.